Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Fundación Jiménez Díaz (7)

2024

  1. COVID-19 and cardiovascular disease in patients with chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 177-189

  2. Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease

    Clinical Kidney Journal, Vol. 17, Núm. 3

2023

  1. Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 10-25

2022

  1. Effectiveness of CPAP vs. Noninvasive Ventilation Based on Disease Severity in Obesity Hypoventilation Syndrome and Concomitant Severe Obstructive Sleep Apnea

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 228-236

2015

  1. Paricalcitol inhibits aldosterone-induced proinflammatory factors by modulating epidermal growth factor receptor pathway in cultured tubular epithelial cells

    BioMed Research International, Vol. 2015

  2. Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases

    Atherosclerosis, Vol. 239, Núm. 2, pp. 358-363

2013

  1. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease

    Journal of Nephrology, Vol. 26, Núm. 6, pp. 1105-1113